{"DataElement":{"publicId":"7114318","version":"1","preferredName":"Tumor Mass Hepatocellular Carcinoma Anatomic Site","preferredDefinition":"The named locations of a benign or malignant pathologic structure in the liver.","longName":"TMR_LIHC_ANAT_SITE","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6796604","version":"1","preferredName":"Tumor Mass Site","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._The anatomic site of the tumor.","longName":"4976411v1.0:6796602v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"4976411","version":"1","preferredName":"Tumor Mass","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","longName":"C98275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC5FA96-6845-8A34-E050-BB89AD4344BC","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-20","modifiedBy":"ONEDATA","dateModified":"2015-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6796602","version":"1","preferredName":"Site of Tumor","preferredDefinition":"The anatomic site of the tumor.","longName":"C157120","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Site of Tumor","conceptCode":"C157120","definition":"The anatomic site of the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C3BB458-85EF-345F-E053-F662850AA4D3","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"ONEDATA","dateModified":"2019-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C3BB458-8600-345F-E053-F662850AA4D3","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"KNABLEJ","dateModified":"2020-01-02","changeDescription":"1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF.   7/26/19 jk revised OC concept per CPTAC input.  6/26/19 jk created for CPTAC Baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7114138","version":"1","preferredName":"Hepatocellular Carcinoma Anatomic Site","preferredDefinition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung._Named locations of or within the body.","longName":"LIHC_ANAT_SITE","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Quadrate Lobe","valueDescription":"Quadrate Lobe of Liver","ValueMeaning":{"publicId":"6403887","version":"1","preferredName":"Quadrate Lobe of Liver","longName":"6403887","preferredDefinition":"An oblong shaped area of the liver that is situated inferior to the right lobe, bounded by the anterior margin of the liver and the porta hepatis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quadrate Lobe of Liver","conceptCode":"C112404","definition":"An oblong shaped area of the liver that is situated inferior to the right lobe, bounded by the anterior margin of the liver and the porta hepatis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73DF7556-1F92-2AB2-E053-F662850AC8AF","latestVersionIndicator":"Yes","beginDate":"2018-08-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-08-20","modifiedBy":"ONEDATA","dateModified":"2018-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB0E7AA-E664-4C17-E053-F662850AD3C6","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Caudate Lobe","valueDescription":"Caudate Lobe","ValueMeaning":{"publicId":"6117917","version":"1","preferredName":"Caudate Lobe","longName":"6117917","preferredDefinition":"Couinaud segment I, located on the posterior surface of the liver between the sulcus for the vena cava and the ligamentum venosum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Caudate Lobe","conceptCode":"C33000","definition":"Couinaud segment I, located on the posterior surface of the liver between the sulcus for the vena cava and the ligamentum venosum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66E01D27-39DA-19F9-E053-F662850AA564","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"HLAINGY","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB0E7AA-E679-4C17-E053-F662850AD3C6","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Left Lobe","valueDescription":"Left Lobe of the Liver","ValueMeaning":{"publicId":"4265502","version":"1","preferredName":"Left Lobe of the Liver","longName":"4265502","preferredDefinition":"The smaller lobe of the liver extending into the left side of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Left Lobe of the Liver","conceptCode":"C32965","definition":"The smaller lobe of the liver extending into the left side of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6A042BB-2CA6-001B-E040-BB89AD43791D","latestVersionIndicator":"Yes","beginDate":"2014-04-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB0E7AA-E68E-4C17-E053-F662850AD3C6","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Right Lobe","valueDescription":"Right Lobe of the Liver","ValueMeaning":{"publicId":"6403558","version":"1","preferredName":"Right Lobe of the Liver","longName":"6403558","preferredDefinition":"The larger lobe of the liver extending into the right side of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Right Lobe of the Liver","conceptCode":"C33481","definition":"The larger lobe of the liver extending into the right side of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73CC1E90-9DB0-0D42-E053-F662850A64ED","latestVersionIndicator":"Yes","beginDate":"2018-08-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-08-19","modifiedBy":"ONEDATA","dateModified":"2018-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB0E7AA-E6A3-4C17-E053-F662850AD3C6","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7114137","version":"1","preferredName":"Hepatocellular Carcinoma Anatomic Site","preferredDefinition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.:Named locations of or within the body.","longName":"C3099:C13717","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma","conceptCode":"C3099","definition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anatomic Site","conceptCode":"C13717","definition":"Named locations of or within the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB0E7AA-E633-4C17-E053-F662850AD3C6","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB0E7AA-E644-4C17-E053-F662850AD3C6","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval. 12/27/19 jk created for CPTAC LIHC baseline, local and path report CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779541","version":"1","longName":"LIHC Baseline","context":"OCCPR"},{"publicId":"6779542","version":"1","longName":"LIHC Local Pathology","context":"OCCPR"},{"publicId":"6779543","version":"1","longName":"LIHC Pathology Review","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Site","type":"Preferred Question Text","description":"Tumor Site","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB30D14-8DC1-4C47-E053-F662850A703A","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval. 1/29/20 jk added CSI for LIHC Path Rev and Local CRFs.  1/27/20 jk upd definition per CPTAC format.  12/27/19 jk created for CPTAC LIHC baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}